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nique of mesh fixation (tacks vs. transfascial sutures) and
its correlation with postoperative pain, as they were surely
aware of the many anecdotal reports of pain at the trans-
fascial suture site. They utilize a prospective telephone fol-
low-up study to evaluate the postoperative pain score and
hope that large differences in the pain score would be vis-
ible despite the small number (50) of patients enrolled.
They conclude that patients undergoing laparoscopic ven-
tral hernia repair with primary transabdominal sutures or
tacks experience similar overall postoperative pain.
I wonder whether the conclusion should have rather been
that their study did not succeed in finding a difference in
pain. Several factors were not considered: (1) Telephone
follow-ups have an inherent reporting bias. Validated
methods of assessing postoperative pain are available that
did not appear to be used here. (2) There seemed to be a
difference in study cohorts. Men have different pain per-
ception that women do, and there appeared to be a differ-
ent distribution in the groups that was not addressed. (3)
Intra- and perioperative pain management have significant
influences on postoperative pain scores (see the work of
the European PROSPECT group). This was also not
addressed.
Again, it is an important effort to investigate postoperative
pain in laparoscopic hernia patients; however, the conclu-
sion as stated in the paper is not supported by the data the
authors provide.
Sincerely,
Juliane Bingener-Casey, MD
Department of Surgery
Mayo Clinic
200 First Street SW
Rochester, Minnesota 55905
Re: JSLS(2008)12:295-298 Natural Orifice Surgery:
Transdouglas Surgery–a New Concept
We read with interest the article Natural Orifice Surgery:
Transdouglas Surgery–a New Concept by Stark M and
Benhidjeb T [JSLS(2008)12:295-298]. The article raises
questions that must be answered.
The designation of the acronym NOS (Natural Orifice
Surgery) does not negate the previous use of a natural
orifice for endoscopic surgery. Transdouglas luminal
endoscopic surgery through the posterior cul-de-sac
(pouch of Douglas) is not a “new concept,” making the
title misleading. This may seem to be an issue of seman-
tics, but it diminishes the accomplishments of those who
have done and reported this type of surgery for over 100
years, as noted in Table 2. Words have meaning, accura-
cy is important, and calling something new when it isn’t
is factually incorrect. Renaming established procedures
does not make them new. Culdoscopy has a long gyne-
cologic tradition and has been recently used for diagnos-
tic and therapeutic purposes in fertiloscopy, a direct
vision procedure.
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The instrument described as TED (Transdouglas
Endoscopic Device) the article says is “being developed.”
This is a preliminary report about an instrument in the
process of development with no animal or human
reports, only “simulated” ones. Simulation is no substitute
for clinical proof. This leap of faith from simulation to
clinical use is without basis. Conclusions formulated by
gedanken are not always as they seem, and their strong
beliefs must be supported by data beyond a physical
description of the device. The article claims that the
shape of the “head” would not “lead to any injury.” How
do they know this? What's the proof? Whatever benefits
the authors conjured up are just that-conjectured up-and
not valid. The assumption that reduced intraabdominal
pressure will result without experimental verification is a
false statement. The database of the article is a physical
and numerical description of the device and not data
about use, safety, or efficacy. 
Patent applications, European or US, must be “reduced to
practice” and able to be reproduced by “one skilled in the
art” when they are applied for. The article says TED is not
complete, not tested, and still under development saying,
“there will be housed in the head,” not there is housed in
the head. “Will be” is the future; “there is” represents
present existence. 
The authors say they “have no commercial associations
that might pose a conflict of interest in connection with
the submitted article, except a patent-pending arrange-
ment for the TED that was assigned by author MS.”
Assignment by “an inventor” to someone else or entity is
done for commercial development with compensation to
the inventor as the authors note for TED’s assignment. In
fact “manufacturing of the device is in progress.” The
integrity of the authors and JSLS are important to preserve
and maintain. There is nothing wrong or inappropriate
with such arrangements, but they must be disclosed and
with straight-forward language, not tortuous exceptions.
JSLS(2009)13:120– 122 121TED has been previously reported by these authors and
not referenced.
2,3 In short, TED is not new, but previous-
ly reported and has no clinical data.
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Authors’ Response
We are not certain that our article was read thoroughly.
use of the pouch of Douglas. Our use of the acronym NOS
rather than the usual NOTES is not new either.1 In the
“Letter to the Editor,” we stated that the “T” in NOTES
stands for transluminal, and because we cannot define the
trans-Douglas route as transluminal, we use the term NOS,
which includes NOTES. The new concept is obviously not
the usage of the pouch of Douglas but the single-entry con-
cept for intraabdominal surgical procedures. 
Our assumption that the head of the instrument will not
cause any injury is based on the fact that there are no sharp
edges, and as for its diameter, we took into account the
results of our group's study concerning the anatomical lim-
its of the pouch of Douglas.2 Assumptions as for the
intraabdominal pressure needed are indeed not equivalent
to evidence-based facts and do not claim to be so. 
The patent-pending arrangements were mentioned on the
first page of the article. 
We thank Dr. Ott and Dr. Redan for mentioning our previ-
ous publications on TED.
Sincerely,
Michael Stark
Tahar Benhidjeb
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In the “Introduction,” we explicitly mentioned the yearlong
1